CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4207-4211

  Schwarze, Jürgen ^a   Cieslewicz, Grzegorz ^a   Joetham, Anthony ^a   Ikemura, Toshihide ^a   Hamelmann, Eckard ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE ANTIBODY; METHACHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LOEFFLER PNEUMONIA; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; BRONCHIAL HYPERREACTIVITY; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILIA; FEMALE; HUMANS; INTERLEUKIN-5; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 0033120971     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Empey, D. W., L. A. Laitinen, L. Jacobs, W. M. Gold, and J. A. Nadel. 1976. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am. Rev. Resp. Dis. 133:131.
2. Busse, W. W. 1990. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J. Allergy Clin. Immunol. 85:671.
3. McIntosh, K., E. F. Ellis, L. S. Hoffman, T. G. Lybass, J. J. Eller, and V. A. Fulginiti. 1973. The association of viral and bacterial respiratory infections with the exacerbation of wheezing in young asthmatic children. J. Pediatr. 82: 578.
4. Sigurs, N., R. Bjarnason, F. Sigurbergsson, B. Kjellman, and B. Björkstén. 1995. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 95:500.
5. Corrigan, C. J., and A. B. Kay. 1990. CD4 T-lymphocyte activation in acute severe asthma. Am. Rev. Resp. Dis. 141:970.
6. Gonzales, M. C., P. Diaz, F. R. Galleguillos, P. Ancic, O. Cromwell, and A. B. Kay. 1987. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma: relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am. Rev. Resp. Dis. 136:600.
7. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J.-C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Resp. Dis. 146:109.
8. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
9. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1 (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477.
10. Hamelmann, E., A. Oshiba, J. Schwarze, K. Bradley, J. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 16:674.
11. - T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am. J. Resp. Crit. Care Med. 157:210.
12. + T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J. Exp. Med. 183:1719.
13. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clones. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
14. + lymphocytes can develop into non-cytolytic CD8 CD4 cells which produce IL-4, IL-5, IL-10, and help B cells. Science 260:1802.
15. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
16. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Resp. Crit. Care Med. 155:819.
17. Lee, N. A., and J. J. Lee. 1997. Asthma: does IL-5 have a more provocative role? Am. J. Respir. Cell Mol. Biol. 16:497.
18. Lukacher, A. E., V. L. Braciale, and T. J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814.
19. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of α/β and γ/δ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123.
20. Fong, T. A., and T. R. Mosmann. 1990. Alloreactive murine T cell clones secrete the Th1 pattern of cytokines. J. Immunol. 144:1744.
21. + cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1229.
22. Schwarze, J., E. Hamelmann, K. L. Bradley, K. Takeda, and E. W. Gelfand. 1997. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J. Clin. Invest. 100:226.
23. Reuman, P. D., S. P. Keely, and G. M. Schiff. 1990. Rapid recovery from RSV infection after combined nasal/oral immunization with killed RSV in mice. J. Med. Virol. 32:67.
24. Toms, G. L., P. S. Gardner, C. R. Pullan, M. Scott, and C. E. Taylor. 1980. Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation. J. Med. Virol. 5:351.
25. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Resp. Crit. Care Med. 156: 766.
26. Oshiba, A., E. Hamelmann, K. Takeda, K. Bradley, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97:1398.
27. Schumacher, J. H., A. O'Garra, B. Shrader, A. van Kimmenade, M. W. Bond, T. R. Mosmann, and R. L. Coffman. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assay. J. Immunol. 141:1576.
28. van Schaik, S. M., G. Enhorning, I. Vargas, and R. C. Welliver. 1998. Respiratory syncytial virus affects pulmonary function in BALB/c mice. J. Infect. Dis. 177: 269.
29. Folkerts, G., B. van Esch, M. Janssen, and F. P. Nijkamp. 1992. Virus induced airway hyperresponsiveness in the guinea pig in vivo: study of bronchoalveolar cell numbers and activity. Eur. J. Pharmacol. 228:219.
30. Anderson, J. J., J. Norden, D. Saunders, G. L. Toms, and R. Scott. 1990. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J. Gen. Virol. 71:1561.
31. Nakajiama, H., G. J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral cosinophils. J. Immunol. 156:4859.
32. Walz, A., P. Peveri, H. Aschauer, and M. Baggiolini. 1987. Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149:755.
33. Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of human monocyte-derived neutrophil chemotactic factor that has peptide sequence similar to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84:9233.
34. Pemberton, R. M., M. J. Cannon, P. J. M. Openshaw, L. A. Ball, G. A. Wertz, and B. A. Askonas. 1987. Cytotoxic T-cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J. Gen. Virol. 68:2177.
35. + T cells control Th-2 driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341.
36. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421.
37. Nicholas, J. A., K. L. Rubino, M. E. Levely, E. G. Adams, and P. L. Collins. 1990. Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. J. Virol. 64:4232.
38. Alwan, W. H., F. M. Record, and P. J. M. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 150:5211.
39. d-restricted cytotoxic T lymphocytes from mice primed by infection. J. Virol. 64: 1683.
40. Alwan, W. H., W. J. Kozlowska, and P. J. M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179: 81.
41. Connors, M., N. A. Geise, A. B. Kulkarni, C. Y. Firestone, H. C. Morse, III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:5321.
42. Tang, Y. W., and B. S. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1953.
43. Cerwenka, A., L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dulton. 1998. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:97.